Insights

Stelis Biopharma receives EU-GMP certification for two of its manufacturing facilities
Stelis Biopharma, the biologics arm of Strides Pharma Science announced that


I Picked A Heck Of A Time
A new CEO’s observations on managing a fast-growing, fully integrated biophar

Stelis starts next phase of investment into its biologics manufacturing facility
This phase sees the CDMO start work on installing two 2,000-L single-use bior

Unit 1 – Bangalore, India
State-of-the-art process and analytical development facilities for small-scal

Unit 2 – Bangalore, India
Integrated state-of-the-art manufacturing facility leverages microbial and ma

Unit 3 – Bangalore, India
A multipurpose facility with an ability to cater to multiple vaccine types in

Meeting Demand for Biologics & Specialty Drugs
A company that provides insurance and investment-related products and service

Overcoming Biologic Drug Formulation Hurdles
A company that provides insurance and investment-related products and service

Stelis concludes US$ 195m Series B and Series C fund raise
Stelis Biopharma (Stelis) today announced that it has successfully concluded
Our Corporate Governance
Policy
Appointment of Independent Director
Notice of General Meeting_FY 22